Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood-Brain Barrier
The incidence of brain metastases has been increasing constantly for the last 20 years, because of better control of metastases outside the brain, and the failure of most drugs to cross the blood-brain barrier at relevant pharmacological concentrations. Recent advances in the molecular biology of ca...
Saved in:
Main Authors: | Eurydice Angeli (Author), Guilhem Bousquet (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Facilitation of Drug Transport across the Blood-Brain Barrier with Ultrasound and Microbubbles
by: Stephen Meairs
Published: (2015) -
Blood-brain Barrier Remodeling during Brain Metastasis Formation
by: Jagoda K Wrobel, et al.
Published: (2016) -
The Cell-Penetrating Peptide Tat Facilitates Effective Internalization of PSD-95 Inhibitors Into Blood-Brain Barrier Endothelial Cells but less Efficient Permeation Across the Blood-Brain Barrier In Vitro and In Vivo
by: Emma Lisa Al Humaidan, et al.
Published: (2022) -
Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents
by: Hari Krishna Ananthula, et al.
Published: (2018) -
Mechanisms of acquired resistance to tyrosine kinase inhibitors
by: Yi-fan Chen, et al.
Published: (2011)